Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |